抗血栓治疗 - 干预病理学家的一个简单算法:一个案例系列
Karen Villar-Zarra1, Jesús Nieves-Alonso2, Héctor-Enrique Torres-Rivas3
1Pathology Department, Hospital Universitario del Henares, Madrid, Spain.
概括
一个新的算法可以在干预性病理学过程中安全地管理抗血栓治疗的患者. 这种实用方法确保了基于更新的抗血栓治疗管理指南的患者安全.
科学领域:
- 医学 医学 医学 医学 医学
- 病理学 病理学 病理学
背景情况:
- 管理正在接受手术的抗血栓治疗患者存在挑战.
- 现有的指导方针需要在干预病理学中得到实际应用.
研究的目的:
- 介绍一种在干预病理学中管理抗血栓治疗的实用算法.
- 根据更新的指南,确保安全的患者护理.
主要方法:
- 开发一个临床算法.
- 适用"抗血栓治疗管理指南".
- 专注于干预性病理学程序.
主要成果:
- 该算法有助于对接受抗血栓治疗的患者进行安全管理.
- 确保遵守新的抗血栓治疗管理指南.
- 为干预性病理学设置提供了一个实用的框架.
结论:
- 开发的算法可以在干预病理学中安全地管理患者.
- 它为遵守新的抗血栓指南的临床医生提供了切实可行的解决方案.
相关概念视频
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
690
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
690
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
522
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
522